Cryoport projects $192M-$196M FY 2026 revenue and expects positive adjusted EBITDA in 2H 2026
CryoPort, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.99
+12% in 3d after detection
Post-detection moves
1h
—
1d
+4.1%
3d
+12%
7d
+8.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS